AC024896.1/miR-363-3p Axis Regulates the Malignant Progression of Acute Myeloid Leukemia by Cuproptosis-Related Gene MYO1B

References

• Khwaja A, Bjorkholm M, Gale RE, et al. Acute myeloid leukaemia. Nat Rev Dis Primers. 2016;2(1):16010. doi:10.1038/nrdp.2016.10
   PubMedGoogle Scholar
• Blackburn LM, Bender S, Brown S. Acute leukemia: diagnosis and treatment. In: Seminars in Oncology Nursing. Elsevier; 2019.
   Google Scholar
• Pui CH, Nichols KE, Yang JJ. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia. Nat Rev Clin Oncol. 2019;16(4):227–240. doi:10.1038/s41571-018-0136-6
   PubMed Web of Science ®Google Scholar
• Buschner G, Feuerecker B, Spinner S, et al. Differentiation of acute myeloid leukemia (AML) cells with ATRA reduces 18 F-FDG uptake and increases sensitivity towards ABT-737-induced apoptosis. Leuk Lymphoma. 2021;62(3):630–639. doi:10.1080/10428194.2020.1839648
   PubMed Web of Science ®Google Scholar
• Tamamyan G, Kadia T, Ravandi F, et al. Frontline treatment of acute myeloid leukemia in adults. Crit Rev Oncol Hematol. 2017;110:20–34. doi:10.1016/j.critrevonc.2016.12.004
   PubMed Web of Science ®Google Scholar
• Estey E, Levine RL, Lowenberg B. Current challenges in clinical development of ”targeted therapies”: the case of acute myeloid leukemia. Blood. 2015;125(16):2461–2466. doi:10.1182/blood-2015-01-561373
   PubMed Web of Science ®Google Scholar
• Ge S, Zhu G, Yi Y. Extramedullary plasmacytoma of the larynx: literature review and report of a case who subsequently developed acute myeloid leukemia. Oncol Lett. 2018;16(3):2995–3004. doi:10.3892/ol.2018.8992
   PubMed Web of Science ®Google Scholar
• Kayser S, Levis MJ. Advances in targeted therapy for acute myeloid leukaemia. Br J Haematol. 2018;180(4):484–500. doi:10.1111/bjh.15032
   PubMed Web of Science ®Google Scholar
• Goto H. Childhood relapsed acute lymphoblastic leukemia: biology and recent treatment progress. Pediatr Int. 2015;57(6):1059–1066. doi:10.1111/ped.12837
   PubMed Web of Science ®Google Scholar
• Guo Y, Luo F, Liu Q, et al. Regulatory non-coding RNA s in acute myocardial infarction. J Cell Mol Med. 2017;21(5):1013–1023. doi:10.1111/jcmm.13032
   PubMed Web of Science ®Google Scholar
• Kharel P, Balaratnam S, Beals N, et al. The role of RNA G-quadruplexes in human diseases and therapeutic strategies. Wiley Interdiscip Rev RNA. 2020;11(1):e1568. doi:10.1002/wrna.1568
   PubMed Web of Science ®Google Scholar
• Almamun M, Levinson BT, van Swaay AC, et al. Integrated methylome and transcriptome analysis reveals novel regulatory elements in pediatric acute lymphoblastic leukemia. Epigenetics. 2015;10(9):882–890. doi:10.1080/15592294.2015.1078050
   PubMed Web of Science ®Google Scholar
• Falzone L, Lupo L, Salemi R, et al. Identification of novel microRNAs and their diagnostic and prognostic significance in oral cancer. Cancers. 2019;11(5):610. doi:10.3390/cancers11050610
   PubMed Web of Science ®Google Scholar
• Mesrian Tanha H, Mojtabavi Naeini M, Rahgozar S, et al. Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment. Tumour Biol. 2016;37(6):7861–7872. doi:10.1007/s13277-015-4553-1
   PubMedGoogle Scholar
• Trino S, Lamorte D, Caivano A, et al. MicroRNAs as new biomarkers for diagnosis and prognosis, and as potential therapeutic targets in acute myeloid leukemia. Int J Mol Sci. 2018;19(2):460. doi:10.3390/ijms19020460
   PubMed Web of Science ®Google Scholar
• Wang LJ, Qiu B-Q, Yuan -M-M, et al. Identification and validation of dilated cardiomyopathy-related genes via bioinformatics analysis. Int J Gen Med. 2022;15:3663–3676. doi:10.2147/IJGM.S350954
   PubMed Web of Science ®Google Scholar
• Lopez-Pajares V. Long non-coding RNA regulation of gene expression during differentiation. Pflugers Arch. 2016;468(6):971–981. doi:10.1007/s00424-016-1809-6
   PubMed Web of Science ®Google Scholar
• Koscianska E, Kozlowska E, Fiszer A. Regulatory potential of competing endogenous RNAs in myotonic dystrophies. Int J Mol Sci. 2021;22(11):6089. doi:10.3390/ijms22116089
   PubMed Web of Science ®Google Scholar
• Yuan CL, Li H, Zhu L, et al. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer. Neoplasma. 2016;63(3):442–449. doi:10.4149/314_150825N45
   PubMed Web of Science ®Google Scholar
• Guo Q, Cheng Y, Liang T, et al. Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression. Sci Rep. 2015;5(1):17683. doi:10.1038/srep17683
   PubMedGoogle Scholar
• Zhou M, Zhao H, Xu W, et al. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer. 2017;16(1):16. doi:10.1186/s12943-017-0580-4
   PubMedGoogle Scholar
• Chandra Gupta S, Nandan Tripathi Y. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets. Int J Cancer. 2017;140(9):1955–1967. doi:10.1002/ijc.30546
   PubMed Web of Science ®Google Scholar
• Sebastiani P, Gurinovich A, Nygaard M, et al. APOE alleles and extreme human longevity. J Gerontol a Biol Sci Med Sci. 2019;74(1):44–51. doi:10.1093/gerona/gly174
   PubMed Web of Science ®Google Scholar
• Chen D, Wang M, Jiang X, et al. Comprehensive analysis of ZFPM2-AS1 prognostic value, immune microenvironment, drug sensitivity, and co-expression network: from gastric adenocarcinoma to pan-cancers. Discov Oncol. 2022;13(1):24. doi:10.1007/s12672-022-00487-0
   PubMedGoogle Scholar
• Qu J, Li M, Zhong W, et al. Competing endogenous RNA in cancer: a new pattern of gene expression regulation. International Journal of Clinical and Experimental Medicine. 2015;8(10):17110.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Su Y, Wang S, et al. Identification of circRNA-lncRNA-miRNA-mRNA competitive endogenous RNA network as novel prognostic markers for acute myeloid leukemia. Genes. 2020;11(8):868. doi:10.3390/genes11080868
   PubMed Web of Science ®Google Scholar
• Cobine PA, Brady DCJMC. Cuproptosis: cellular and molecular mechanisms underlying copper-induced cell death. Molecular Cell. 2022;82(10):1786–1787. doi:10.1016/j.molcel.2022.05.001
   PubMed Web of Science ®Google Scholar
• da Silva DA, De Luca A, Squitti R, et al. Copper in tumors and the use of copper-based compounds in cancer treatment. Journal of Inorganic Biochemistry. 2022;226:111634. doi:10.1016/j.jinorgbio.2021.111634
   PubMed Web of Science ®Google Scholar
• Chen YH, Xu N-Z, Hong C, et al. Myo1b promotes tumor progression and angiogenesis by inhibiting autophagic degradation of HIF-1alpha in colorectal cancer. Cell Death Dis. 2022;13(11):939. doi:10.1038/s41419-022-05397-1
   PubMed Web of Science ®Google Scholar
• Wang A, Dai H, Gong Y, et al. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis. J Exp Clin Cancer Res. 2019;38(1):347. doi:10.1186/s13046-019-1340-7
   PubMed Web of Science ®Google Scholar
• Wen L-J, Hu X-L, Li C-Y, et al. Myosin 1b promotes migration, invasion and glycolysis in cervical cancer via ERK/HIF-1α pathway. American Journal of Translational Research. 2021;13(11):12536.
   PubMed Web of Science ®Google Scholar
• Sharma A, Yadav D, Rao P, et al. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis. Computers in Biology and Medicine. 2022;146:105688. doi:10.1016/j.compbiomed.2022.105688
   PubMedGoogle Scholar
• Piddock RE, Bowles KM, Rushworth SA. The role of PI3K isoforms in regulating bone marrow microenvironment signaling focusing on acute myeloid leukemia and multiple myeloma. Cancers. 2017;9(4):29. doi:10.3390/cancers9040029
   PubMed Web of Science ®Google Scholar
• Newell LF, Cook RJJB. Advances in acute myeloid leukemia. BMJ. 2021;375.
   PubMedGoogle Scholar
• Pan JQ, Zhang Y-Q, Wang J-H, et al. lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia. Int J Mol Med. 2017;39(3):663–671. doi:10.3892/ijmm.2017.2888
   PubMed Web of Science ®Google Scholar
• Liang C, Li Y, Wang L-N, et al. Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238. Hematology. 2021;26(1):16–25. doi:10.1080/16078454.2020.1860187
   PubMed Web of Science ®Google Scholar
• Zhao TF, Jia H-Z, Zhang -Z-Z, et al. LncRNA H19 regulates ID2 expression through competitive binding to HSA-miR-19a/b in acute myelocytic leukemia. Mol Med Rep. 2017;16(3):3687–3693. doi:10.3892/mmr.2017.7029
   PubMed Web of Science ®Google Scholar
• Uthaya Kumar DB, Williams A. Long non-coding RNAs in immune regulation and their potential as therapeutic targets. Int Immunopharmacol. 2020;81:106279. doi:10.1016/j.intimp.2020.106279
   PubMed Web of Science ®Google Scholar
• Zhao T, Liu XJERMPS. LncRNA-H19 inhibits apoptosis of acute myeloid leukemia cells via targeting miR-29a-3p. European Review for Medical and Pharmacological Sciences. 2019;23(3 Suppl):224–231. doi:10.26355/eurrev_201908_18651
   PubMedGoogle Scholar
• Ng M, Heckl D, Klusmann JH. The regulatory roles of long noncoding RNAs in acute myeloid leukemia. Front Oncol. 2019;9:570. doi:10.3389/fonc.2019.00570
   PubMed Web of Science ®Google Scholar
• Hassani S, Ghaffari P, Chahardouli B, et al. Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes. Biomed Pharmacother. 2018;99:561–569. doi:10.1016/j.biopha.2018.01.109
   PubMed Web of Science ®Google Scholar
• Banerjee K, Das S, Sarkar A, et al. A copper chelate induces apoptosis and overcomes multidrug resistance in T-cell acute lymphoblastic leukemia through redox imbalance and inhibition of EGFR/PI3K/Akt expression. Biomed Pharmacother. 2016;84:71–92. doi:10.1016/j.biopha.2016.08.056
   PubMed Web of Science ®Google Scholar
• Mentes A, Huehn A, Liu X, et al. High-resolution cryo-EM structures of actin-bound myosin states reveal the mechanism of myosin force sensing. Proc Natl Acad Sci U S A. 2018;115(6):1292–1297. doi:10.1073/pnas.1718316115
   PubMed Web of Science ®Google Scholar
• Li SH, Qian L, Chen Y-H, et al. Targeting MYO1B impairs tumorigenesis via inhibiting the SNAI2/cyclin D1 signaling in esophageal squamous cell carcinoma. Journal of Cellular Physiology. 2022;237(9):3671–3686. doi:10.1002/jcp.30831
   PubMed Web of Science ®Google Scholar
• Naughton FB, Becker P, Brotherton D, et al. Substrate binding and conformational changes of the bile acid symporter ASBTNM. Biophys J. 2019;116(3):552a–553a. doi:10.1016/j.bpj.2018.11.2972
   Web of Science ®Google Scholar
• Wee NK, Weinstein DC, Fraser ST, et al. The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease. Int J Biochem Cell Biol. 2013;45(5):960–963. doi:10.1016/j.biocel.2013.01.018
   PubMed Web of Science ®Google Scholar
• Yamada Y, Koshizuka K, Hanazawa T, et al. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma. Int J Oncol. 2018;52(1):166–178. doi:10.3892/ijo.2017.4190
   PubMed Web of Science ®Google Scholar
• Shimonosono M, Idichi T, Seki N, et al. Molecular pathogenesis of esophageal squamous cell carcinoma: identification of the antitumor effects of miR‑145‑3p on gene regulation. Int J Oncol. 2019;54(2):673–688. doi:10.3892/ijo.2018.4657
   PubMed Web of Science ®Google Scholar